Should the drug companies have their diagnostic clinics.
dc.contributor.author | Jain, P C | en_US |
dc.date.accessioned | 2003-10-01 | en_US |
dc.date.accessioned | 2009-05-31T07:25:14Z | |
dc.date.available | 2003-10-01 | en_US |
dc.date.available | 2009-05-31T07:25:14Z | |
dc.date.issued | 2003-10-01 | en_US |
dc.identifier.citation | Jain PC. Should the drug companies have their diagnostic clinics. Journal of the Indian Medical Association. 2003 Oct; 101(10): 608 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/96871 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.jimaonline.org.in/ | en_US |
dc.subject.mesh | Conflict of Interest | en_US |
dc.subject.mesh | Drug Industry | en_US |
dc.subject.mesh | Health Facilities, Proprietary | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | India | en_US |
dc.subject.mesh | Pharmaceutical Preparations | en_US |
dc.title | Should the drug companies have their diagnostic clinics. | en_US |
dc.type | Letter | en_US |
Files
License bundle
1 - 1 of 1